Transgene

Transgene Buyback Yield

The Buyback Yield of Transgene (TNG.PA) as of Nov 18, 2026 is 0.07 %.

Buyback Yield

0.07 %

Last updated:

Buyback Yield of Transgene is 2024 0.07 % . Buyback Yield of Transgene was 2023 0.00 . It decreases by % higher compared to the previous year.

The Transgene Buyback Yield history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Buyback Yield
Date
Buyback Yield
Jan 1, 2017
5.70 EUR
Jan 1, 2018
0.00 EUR
Jan 1, 2019
20.16 EUR
Jan 1, 2020
0.00 EUR
Jan 1, 2021
14.32 EUR
Jan 1, 2022
0.00 EUR
Jan 1, 2023
0.00 EUR
Jan 1, 2024
0.07 EUR
The Transgene Buyback Yield history
YEARBuyback YieldYoY
0.07 %—
0.00—
0.00-100.00%
14.32 %—
0.00-100.00%
20.16 %—
0.00-100.00%
5.70 %-70.56%
19.36 %+9,350.73%
0.20 %—
0.00—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Transgene Stock analysis

What does Transgene do? Transgene SA is a French biotechnology company specializing in the development and production of therapeutics, with a focus on cancer medications. It has a strong patent portfolio in the field of viral vectors, which are used for targeted gene therapy. The company's main areas of operation are clinical trials, research, and production. Transgene has research and production facilities in Strasbourg and Lyon, with over 100 employees. It has established partnerships with pharmaceutical companies, including Takeda Pharmaceuticals, for the development and marketing of therapeutics. Its flagship product, OncoVir-1®, is an immunomodulator that stimulates the immune system to fight tumor cells. Another promising product is TG4010, a therapeutic vaccine for non-small cell lung carcinoma. Transgene is an emerging company with a promising portfolio of cancer therapeutics, leveraging its expertise in viral vectors and collaborating closely with industry partners to expedite the development of marketable products. Transgene is expected to play a significant role in the development of new and innovative cancer treatments. Transgene is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Transgene stock

Buyback Yield of Transgene is 0.07 % in 2024.

On Eulerpool you can find the complete historical development of Buyback Yield Transgene since 2006 – with annual values, charts, and detailed analysis.

Buyback yield measures the percentage of market cap returned to shareholders through share repurchases. It complements dividend yield in assessing total shareholder returns.

To evaluate Buyback Yield's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Buyback Yield.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Buyback Yield's Transgene with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Transgene

All Key Metrics — Transgene